Does CARMUSTINE Cause Product use in unapproved indication? 136 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Product use in unapproved indication have been filed in association with CARMUSTINE (carmustine). This represents 4.0% of all adverse event reports for CARMUSTINE.
136
Reports of Product use in unapproved indication with CARMUSTINE
4.0%
of all CARMUSTINE reports
47
Deaths
55
Hospitalizations
How Dangerous Is Product use in unapproved indication From CARMUSTINE?
Of the 136 reports, 47 (34.6%) resulted in death, 55 (40.4%) required hospitalization, and 17 (12.5%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARMUSTINE. However, 136 reports have been filed with the FAERS database.
What Other Side Effects Does CARMUSTINE Cause?
Off label use (454)
Febrile neutropenia (297)
Myelodysplastic syndrome (295)
Disease progression (241)
Acute myeloid leukaemia (180)
Thrombocytopenia (174)
Pyrexia (152)
Drug ineffective (149)
Mucosal inflammation (148)
Second primary malignancy (141)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which CARMUSTINE Alternatives Have Lower Product use in unapproved indication Risk?
CARMUSTINE vs CARTEOLOL
CARMUSTINE vs CARVEDILOL
CARMUSTINE vs CASIMERSEN
CARMUSTINE vs CASIRIVIMAB
CARMUSTINE vs CASIRIVIMAB\IMDEVIMAB